SAN FRANCISCO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema", "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that the Company will present at the following upcoming investor conferences in September:
- Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a Fireside Chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York on Monday, September 11, 2023, at 10:40 a.m. ET.
- Dr. Bohen will participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference in New York on Tuesday, ...